The pharmaceutical R & D service industry (CXO) concept stocks listed in mainland China and Hong Kong generally have risen on Wednesday (June 12). The market has interpreted this as the US Biological Safety Act legislation.
In terms of A shares, Wanbang Pharmaceutical rose over 14%, Yaoming Kangde rose more than 7%, and once rose by nearly 9%; Kang Longcheng and Kailei rose more than 5%.
In terms of Hong Kong stocks, Yaoming creatures rose more than 14%, Yaoming's union rose nearly 12%, Yaoming Kant rose about 8%, and Kang Longhua became more than 6%.
According to the Securities Times website, the U.S. House of Representatives Supervision and Accountability Committee held a hearing on the latest revised draft biological security bill last month and passed it with high tickets.However, in the subsequent legislative process, the bill failed to be included in the 2025 fiscal law of defense authorization, which caused the market to re -evaluate the prospect of the bill.
The market is generally interpreted as that the legislative work of the bill has been technically aborted, which is undoubtedly good news for a public research and development and production organization company such as Yin Ming Kant.
However, the 21st Century Economic Herald reporters contacted the Washington Genic Investor Relations Department as investors. Regarding whether the bill will make new progress, the relevant personnel responded that this is not that this company can determine that the listed company can determineof.
U.S. Revised Biological Safety Act will allow pharmaceutical companies to follow with January 1, 2032, 2032, 2032, January 1, 2032, 2032, January 1, 2032The "attracted" biomedical company is decoupled.The bill aims to weaken China's influence in the United States.Prior to that, the regulations will not apply to contracts signed with some companies at least 60 days before the release of the regulations.
The draft will provide companies named Yaoming Kant and other bills for several years, reorganizing business to reduce financial impact.The new version of the draft is also named Yaoming creatures that belong to the "Yaoming Department".The two jointly provide research and production support for most large pharmaceutical companies in the world and dozens of smaller innovation companies in the industry.
